References: D'Alessandro A, Kriebardis AG, Rinalducci S, Antonelou MH, Hansen KC, Papassideri IS, et al. An update on red blood cell storage lesions, as gleaned through biochemistry and omics technologies. Transfusion. 2015;55:205-19.
Yoshida T, Prudent M, D'Alessandro A. Red blood cell storage lesion: causes and potential clinical consequences. Blood Transfus. 2019;17:27-52.
Roback JD, Josephson CD, Waller EK, Newman JL, Karatela S, Uppal K, et al. Metabolomics of ADSOL (AS-1) red blood cell storage. Transfus Med Rev. 2014;28:41-55.
Reisz JA, Wither MJ, Dzieciatkowska M, Nemkov T, Issaian A, Yoshida T, et al. Oxidative modifications of glyceraldehyde 3-phosphate dehydrogenase regulate metabolic reprogramming of stored red blood cells. Blood. 2016;128:e32-42.
Lacroix J, Hébert P, Fergusson D, Tinmouth A, Blajchman MA, Callum J, et al. The age of blood evaluation (ABLE) randomized controlled trial: study design. Transfus Med Rev. 2011;25:197-205.
Shah A, McKechnie S, Brunskill SJ, Stanworth SJ. Fresh versus old red cell transfusions: what have the recent clinical trials found? Curr Opin Hematol. 2016;23:550-6.
Lagerberg JW, Korsten H, Van Der Meer PF, De Korte D. Prevention of red cell storage lesion: a comparison of five different additive solutions. Blood Transfus. 2017;15:456-62.
Roback JD. Perspectives on the impact of storage duration on blood quality and transfusion outcomes. Vox Sang. 2016;111:357-64.
Blake JT, Hardy M, Delage G, Myhal G. Déjà-vu all over again: using simulation to evaluate the impact of shorter shelf life for red blood cells at Héma-Québec. Transfusion. 2013;53:1544-58.
Baesler F, Nemeth M, Martínez C, Bastías A. Analysis of inventory strategies for blood components in a regional blood center using process simulation. Transfusion. 2014;54:323-30.
Pi D, Shih AW, Sham L, Zamar D, Roland K, Hudoba M. Establishing performance management objectives and measurements of red blood cell inventory planning in a large tertiary care hospital in British Columbia, Canada. ISBT Sci Ser. 2018;14:226-38.
R Core Team. R: a language and environment for statistical computing (R Version 4.0. 3, R Foundation for Statistical Computing, Vienna, Austria, 2020). 2021.
Fergusson DA, Hébert P, Hogan DL, LeBel L, Rouvinez-Bouali N, Smyth JA, et al. Effect of fresh red blood cell transfusions on clinical outcomes in premature, very low-birth-weight infants: the ARIPI randomized trial. JAMA. 2012;308:1443-51.
Fernandes da Cunha DH, Nunes Dos Santos AM, Kopelman BI, Areco KN, Guinsburg R, de Araújo PC, et al. Transfusions of CPDA-1 red blood cells stored for up to 28 days decrease donor exposures in very low-birth-weight premature infants. Transfus Med. 2005;15:467-73.
Hébert PC, Chin-Yee I, Fergusson D, Blajchman M, Martineau R, Clinch J, et al. A pilot trial evaluating the clinical effects of prolonged storage of red cells. Anesth Analg. 2005;100:1433-58.
Schulman CI, Nathe K, Brown M, Cohn SM. Impact of age of transfused blood in the trauma patient. J Trauma. 2002;52:1224-5.
Steiner ME, Ness PM, Assmann SF, Triulzi DJ, Sloan SR, Delaney M, et al. Effects of red-cell storage duration on patients undergoing cardiac surgery. N Engl J Med. 2015;372:1419-29.
Ng MSY, David M, Middelburg RA, Ng ASY, Suen JY, Tung JP, et al. Transfusion of packed red blood cells at the end of shelf life is associated with increased risk of mortality - a pooled patient data analysis of 16 observational trials. Haematologica. 2018;103:1542-8.
Taylor RW, O'Brien J, Trottier SJ, Manganaro L, Cytron M, Lesko MF, et al. Red blood cell transfusions and nosocomial infections in critically ill patients. Crit Care Med. 2006;34:2302-8; quiz 2309.
Zallen G, Offner PJ, Moore EE, Blackwell J, Ciesla DJ, Gabriel J, et al. Age of transfused blood is an independent risk factor for postinjury multiple organ failure. Am J Surg. 1999;178:570-2.
Fontaine MJ, Chung YT, Erhun F, Goodnough LT. Age of blood as a limitation for transfusion: potential impact on blood inventory and availability. Transfusion. 2010;50:2233-9.
Grasas A, Pereira A, Bosch MA, Ortiz P, Puig L. Feasibility of reducing the maximum shelf life of red blood cells stored in additive solution: a dynamic simulation study involving a large regional blood system. Vox Sang. 2015;108:233-42.
Joint UKBTS professional advisory committee (1) summary sheet. Temporary extension of shelf life of red cells to 42 days. [cited 2020 April 2]. Available from: https://www.transfusionguidelines.org/document-library/documents/jpac-20-26-42-day-red-cell-specification-april-2020-jpac-website-pdf/.
Callum JL, Waters JH, Shaz BH, Sloan SR, Murphy MF. The AABB recommendations for the choosing wisely campaign of the American Board of Internal Medicine. Transfusion. 2014;54:2344-52.
Dunbar NM, Yazer MH. O- product transfusion, inventory management, and utilization during shortage: the OPTIMUS study. Transfusion. 2018;58:1348-55.
Zehnder L, Schulzki T, Goede JS, Hayes J, Reinhart WH. Erythrocyte storage in hypertonic (SAGM) or isotonic (PAGGSM) conservation medium: influence on cell properties. Vox Sang. 2008;95:280-7.
D'Alessandro A, Nemkov T, Hansen KC, Szczepiorkowski ZM, Dumont LJ. Red blood cell storage in additive solution-7 preserves energy and redox metabolism: a metabolomics approach. Transfusion. 2015;55:2955-66.
Pallotta V, Gevi F, D'Alessandro A, Zolla L. Storing red blood cells with vitamin C and N-acetylcysteine prevents oxidative stress-related lesions: a metabolomics overview. Blood Transfus. 2014;12:376-87.
Yoshida T, AuBuchon JP, Tryzelaar L, Foster KY, Bitensky MW. Extended storage of red blood cells under anaerobic conditions. Vox Sang. 2007;92:22-31.
Nogueira D, Rocha S, Abreu E, Costa E, Santos-Silva A. Biochemical and cellular changes in leukocyte-depleted red blood cells stored for transfusion. Transfus Med Hemother. 2015;42:46-51.
Blood Component Manufacturing, Canadian Blood Services website. [cited 2023 February 11]. Available from: https://www.blood.ca/en/hospital-services/products/component-manufacturing/blood-component-manufacturing.
No Comments.